EUVIMED · CrossrefZeitschrift
Current Breast Cancer Reports
ISSN 1943-4588 · Springer Science and Business Media LLC
Neueste Artikel
Active Surveillance of Ductal Carcinoma In-Situ
Locoregional Considerations for Invasive Lobular Carcinoma
Circulating Tumor DNA in Metastatic Breast Cancer: Current Clinical Applications and Future Directions
Surgical Nodal Staging for Ductal Carcinoma In Situ: When to Omit, When to Delay, and What Comes Next?
Targeting PARP1: A Promising Approach for Next-Generation Poly (ADP-ribose) Polymerase Inhibitors
Survivorship Issues in Older Adults with Breast Cancer
A Brief History and the Current State of Robotic Mastectomy: a Review
Dietary Strategies for Breast Cancer Survivorship: From Evidence to Practice
Emerging Clinical Applications for Cone Beam Breast CT: Changing the Breast Imaging Paradigm
Long-Term Considerations for Young Breast Cancer Patients: Fertility, Sexual Health, and Quality of Life
The Future of Lymphedema: Potential Therapeutic Targets for Treatment
Metastatic Triple-Negative Breast Cancer
Breast Cancer Clinical Trials in East Africa
Robot-assisted Nipple Sparing Mastectomy: Recent Advancements and Ongoing Controversies
Allostatic Load and Breast Cancer: a Systematic Review of the Literature
I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Obesity, Dietary Factors, Nutrition, and Breast Cancer Risk
Oncoplastic Breast Surgery: What, When and for Whom?
Illness Perceptions in Women with Breast Cancer—a Systematic Literature Review
Targets for the Action of Phytoestrogens in Breast Cancer—Focus on Isoflavones and Resveratrol
Breast Cancer Biomarkers: Utility in Clinical Practice
Weight Loss Intervention for Breast Cancer Survivors: A Systematic Review
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer
The role of adjuvant anthracyclines for breast cancer treatment: Can we use molecular predictors?
How do we evaluate sentinel nodes and interpret the findings?
Neoadjuvant therapy for breast cancer: Assessing treatment progress and managing poor responders
Concurrent use of chemotherapy or novel agents in combination with radiation in breast cancer
What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?
Is chemoprevention practical?
EUVIMED